MYPIKTRI Trademark
Trademark Overview
On Wednesday, August 23, 2017, a trademark application was filed for MYPIKTRI with the United States Patent and Trademark Office. The USPTO has given the MYPIKTRI trademark a serial number of 79219678. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, May 21, 2024. This trademark is owned by NOVARTIS AG. The MYPIKTRI trademark is filed in the Pharmaceutical Products category with the following description:
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pre...
General Information
Serial Number | 79219678 |
Word Mark | MYPIKTRI |
Filing Date | Wednesday, August 23, 2017 |
Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
Status Date | Tuesday, May 21, 2024 |
Registration Number | 5415231 |
Registration Date | Tuesday, March 6, 2018 |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, December 19, 2017 |
Trademark Statements
Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | H - NOT AVAILABLE |
Class Status Date | Tuesday, June 8, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | NOVARTIS AG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Party Name | NOVARTIS AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Party Name | NOVARTIS AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Trademark Events
Event Date | Event Description |
Thursday, October 26, 2017 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
Friday, October 27, 2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Tuesday, October 31, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, November 2, 2017 | ASSIGNED TO EXAMINER |
Saturday, November 4, 2017 | APPLICATION FILING RECEIPT MAILED |
Thursday, November 9, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, November 29, 2017 | NOTICE OF PUBLICATION |
Tuesday, December 19, 2017 | PUBLISHED FOR OPPOSITION |
Tuesday, March 6, 2018 | REGISTERED-PRINCIPAL REGISTER |
Thursday, April 5, 2018 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
Friday, April 13, 2018 | FINAL DISPOSITION PROCESSED |
Friday, April 13, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
Friday, May 4, 2018 | NOTIFICATION PROCESSED BY IB |
Sunday, June 27, 2021 | DEATH OF INTERNATIONAL REGISTRATION |
Sunday, June 27, 2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
Sunday, June 12, 2022 | NOTIFICATION PROCESSED BY IB |
Monday, December 16, 2024 | DEATH OF INTERNATIONAL REGISTRATION |